Literature DB >> 22185536

Premature rupture of membranes before 28 weeks managed expectantly: maternal and perinatal outcomes in a developing country.

G L Fernandes1, M R Torloni, W Jou Hisaba, D Klimke, J Novaes, M Sancovski, S Peixoto.   

Abstract

This study aimed to assess outcomes of expectant management for early preterm premature rupture of membranes (PPROM). This retrospective cohort involved 66 women with PPROM <28 weeks managed in a single hospital (1999-2006). Main outcomes were chorioamnionitis, severe maternal morbidity (maternal sepsis, haemorrhage/blood transfusion, hysterectomy or admission to intensive care unit), maternal mortality, low birth weight, preterm birth, neonatal infection and perinatal mortality. Mean gestational ages at PPROM and delivery were 21.7 ± 4.2 and 28.4 ± 5.9 weeks, respectively. Chorioamnionitis was diagnosed in 47%; no cases of severe maternal morbidity or mortality occurred. Stillbirth rate was 25.7% and >80% of infants were delivered before 34 weeks. Neonatal infection was diagnosed in 42.9% of the 49 live-births. Overall survival rate was 57.6%. Expectant management of PPROM <28 weeks resulted in high rates of chorioamnionitis and preterm deliveries but in over half of the cases, a live infant was discharged home.

Entities:  

Mesh:

Year:  2012        PMID: 22185536     DOI: 10.3109/01443615.2011.609923

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Epidemiological profile of patients with preterm premature rupture of membranes at a tertiary hospital in São Paulo, Brazil.

Authors:  Marco Aurélio Knippel Galletta; Roberto Eduardo Bittar; Isabela Agra; Eliane Cerqueira Leite Guerra; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2019-10-21       Impact factor: 2.365

2.  Determinants of Premature Rupture of Membranes Among Pregnant Women Admitted to Public Hospitals in Southern Ethiopia, 2020: A Hospital-Based Case-Control Study.

Authors:  Aklilu Habte; Samuel Dessu; Kaleegziabher Lukas
Journal:  Int J Womens Health       Date:  2021-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.